Clinical Trial Update: EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

View source ↗

Summary

EVITA is a completed study monitoring Epstein-Barr virus infection in renal transplant recipients; the snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebv Viremia
• Epstein-barr Virus Infection
• Epstein-barr Virus-associated Lymphoproliferative Disorder
• Post-transplant Lymphoproliferative Disorder

Snippet

Sponsor: University of Aarhus | Conditions: EBV Infection, EBV Viremia | Status: COMPLETED